UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

Journal of the American Academy of Child and Adolescent Psychiatry, 2008, Vol.47 (1), p.21-31

2008

Volltextzugriff (PDF)

Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff

Addiction science & clinical practice, 2018-04, Vol.13 (1), p.8-8, Article 8

2018

Volltextzugriff (PDF)

A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction

PloS one, 2019-11, Vol.14 (11), p.e0224399

2019

Volltextzugriff (PDF)

Cingulate-Precuneus Interactions: A New Locus of Dysfunction in Adult Attention-Deficit/Hyperactivity Disorder

Biological psychiatry (1969), 2008-02, Vol.63 (3), p.332-337

2008

Volltextzugriff (PDF)

A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS)

The American journal of medicine, 2015-07, Vol.128 (7), p.784.e9-784.e19

2015

Volltextzugriff (PDF)

Brain macrostructural and microstructural abnormalities in cocaine dependence

Drug and alcohol dependence, 2008-01, Vol.92 (1), p.164-172

2008

Volltextzugriff (PDF)

A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction

PloS one, 2018-06, Vol.13 (6), p.e0199951

2018

Volltextzugriff (PDF)

Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial

Trials, 2024-01, Vol.25 (1), p.67-17, Article 67

2024

Volltextzugriff (PDF)

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)"

Addiction science & clinical practice, 2021-03, Vol.16 (1), p.15-15, Article 15

2021

Volltextzugriff (PDF)

Drug Addiction and Stress‐Response Genetic Variability: Association Study in African Americans

Annals of human genetics, 2014-07, Vol.78 (4), p.290-298

2014

Volltextzugriff (PDF)

Test–retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients

Journal of substance abuse treatment, 2014-07, Vol.47 (1), p.93-101

2014

Volltextzugriff (PDF)

Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients

Addiction science & clinical practice, 2023-09, Vol.18 (1), p.56-11, Article 56

2023

Volltextzugriff (PDF)

Where’s Our Lin Zexu? A Call for Leadership and Resources to Address the Opioid Epidemic

The American journal of psychiatry, 2018-06, Vol.175 (6), p.495-497

Rotrosen, John

2018

Volltextzugriff (PDF)

Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study

Biological psychiatry (1969), 2002-06, Vol.51 (11), p.890-895

2002

Volltextzugriff (PDF)

Inferior Frontal White Matter Anisotropy and Negative Symptoms of Schizophrenia: A Diffusion Tensor Imaging Study

The American journal of psychiatry, 2003-03, Vol.160 (3), p.572-574

2003

Volltextzugriff (PDF)

Under-representation of key demographic groups in opioid use disorder trials

Drug and alcohol dependence reports, 2022-09, Vol.4, p.100084, Article 100084

2022

Volltextzugriff (PDF)

In Memoriam: Burton M. Angrist, MD

Neuropsychopharmacology (New York, N.Y.), 2024-11, Vol.49 (12), p.1947-1948

2024

Volltextzugriff (PDF)

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Contemporary clinical trials, 2016-09, Vol.50, p.253-264

2016

Volltextzugriff (PDF)

Menstrual cycle phase effects on prepulse inhibition of acoustic startle

Psychophysiology, 2004-05, Vol.41 (3), p.401-406

2004

Volltextzugriff (PDF)

Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders

The Lancet (British edition), 2013-09, Vol.382 (9896), p.995-997

2013

Volltextzugriff (PDF)

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment

Drug and alcohol dependence reports, 2022-12, Vol.5, p.100128, Article 100128

2022

Volltextzugriff (PDF)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and alcohol dependence reports, 2022-12, Vol.5, p.100100, Article 100100

2022

Volltextzugriff (PDF)

Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study

Addiction science & clinical practice, 2021-03, Vol.16 (1), p.16-16, Article 16

2021

Volltextzugriff (PDF)

Substance-use screening and interventions in dental practices: survey of practice-based research network dentists regarding current practices, policies and barriers

The Journal of the American Dental Association (1939), 2013-06, Vol.144 (6), p.627

2013

Volltextzugriff (PDF)

Effects of d-cycloserine on negative symptoms in schizophrenia

Schizophrenia research, 2004-12, Vol.71 (2), p.239-248

2004

Volltextzugriff (PDF)

1 – 25 von 335

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(293)
Mit Volltextzugriff
(274)

Publikationsform

Sprache

Englisch
(335)

Erscheinungsjahr

n.n

Thema

Science & Technology
(247)
Life Sciences & Biomedicine
(245)
Humans
(226)
Male
(155)
Psychiatry
(136)
Adult
(123)
Female
(99)
Biological And Medical Sciences
(94)
Middle Aged
(86)
Medical Sciences
(84)
Substance Abuse
(83)
Neurosciences & Neurology
(58)
Pharmacology & Pharmacy
(57)
Psychology. Psychoanalysis. Psychiatry
(56)
Neurosciences
(52)
Substance Abuse Treatment
(51)
Drug Abuse
(45)
Opioid-Related Disorders - Drug Therapy
(44)
Psychopathology. Psychiatry
(43)
Narcotics
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff

A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction

Cingulate-Precuneus Interactions: A New Locus of Dysfunction in Adult Attention-Deficit/Hyperactivity Disorder

A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS)

Brain macrostructural and microstructural abnormalities in cocaine dependence

A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction

Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)"

Drug Addiction and Stress‐Response Genetic Variability: Association Study in African Americans

Test–retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients

Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients

Where’s Our Lin Zexu? A Call for Leadership and Resources to Address the Opioid Epidemic

Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study

Inferior Frontal White Matter Anisotropy and Negative Symptoms of Schizophrenia: A Diffusion Tensor Imaging Study

Under-representation of key demographic groups in opioid use disorder trials

In Memoriam: Burton M. Angrist, MD

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Menstrual cycle phase effects on prepulse inhibition of acoustic startle

Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study

Substance-use screening and interventions in dental practices: survey of practice-based research network dentists regarding current practices, policies and barriers

Effects of d-cycloserine on negative symptoms in schizophrenia

Suchergebnisse filtern